In general, the best results with regard to both yields and
stereoselectivities were obtained with neutral, aliphatic amino
acids (entries 1, 2, 3, 4, and 8, Table 1). Also, there is a marked
stereochemical dependence on the amino acids deployed
(compare entries 1 and 2, Table 1). The highest enantioselec-
tivities were obtained using β-branched amino acids (with the
exception of phenylalanine and asparagine, entries 6 and 8,
Table 1). Consequently, we selected isoleucine to test this
amino acid in cross-aldol additions of isobutyraldehyde with
enolizable and nonenolizable aldehydes.
The results of this investigation are depicted in Table 2.
Differences to proline catalysis and similarities and differ-
ences to histidine catalysis were noticed. First of all, aldol
adducts 7aꢀf are not accessible by proline catalysis for
chemoselectivity reasons.7 Like histidine catalysis, a high
chemoselectivity was observed. Isoleucine strictly differ-
entiates between electron-rich and electron-deficient alde-
hydes. Isobutyraldehyde 1, an electron-rich aldehyde,
reacts exclusively as an enamine component whereas
electron-deficient aldehydes 3, 4, 5, and 6 act as carbonyl
components in isoleucine-catalyzed aldol additions.
In contrast to L-proline and L-histidine catalysis, oppo-
site configured aldol adducts 7bꢀf were detected with
L-isoleucine. The aldol adducts 7bꢀd were also isolated
with good enantioselectivities. Complete enantioselectivity
was observed when using with oxygen-containing alde-
hydes 5 and 6. An exception was the self-aldol addition of
isobutyraldehyde 1. No enantioselectivity was observed;
aldol adduct 7a was isolated in racemic form. Moreover,
substantial amounts of the corresponding aminoacetal 8a
were detected (65%, Table 2). This compound was isolated
in enantiopure form.8
Aminoacetals were also encountered as side products
when benzyloxyacetaldehyde 6 was employed (entry 6,
Table 2). In addition to aldol adduct 7f (ee >98%)
enantiopure isobutyracetal 8f was isolated with 21% yield.
These results prompted us to look more closely at the
stereochemical events of this reaction. To this end, iso-
butyraldehyde 1 was reacted with isovaleraldehyde 9 in the
presence of L-isoleucine. A mixture of aldol adduct 7g and
corresponding acetals 8g and 8h was detected. The aldol
adduct 7g was obtained in racemic form (19% yield). The
aminoacetals 8g and 8h differ in the aldehyde component,
as can be seen in Scheme 1.
After straightforward separation of the acetals and acidic
treatment, the aldol adduct 7g was isolated in enantiopure
form (46% yield). Isoleucine strictly differentiates between
isobutyraldehyde 1 (R-branched aldehyde) as an enamine
component and isovaleraldehyde 9 as a carbonyl compo-
nent. Self-aldol adducts or reversed aldol adducts (in this
case isovaleraldehyde 9 acts as the enol component) were
not observed under these reaction conditions. In addition,
formation of the corresponding aminoacetals 8aꢀf of iso-
lated aldol adducts 7aꢀf was not accomplished under the
described reaction conditions. These results indicate two
reaction modes, which may operate with different rates
under these conditions. One mode proceeds without stereo-
control. The other one, the stereocontrolled mode, runs
through acetalization, which yields indeed enantiopure
aldol adducts. These considerations are supported by the
experiments depicted in Scheme 1.
Scheme 1. Isoleucine-Catalyzed Aldol Addition of Isobutyral-
dehyde and Isovaleraldehydea
Table 2. Isoleucine-Catalyzed Cross Aldol Addition between
Enolizable Aldehydes
7aꢀf
yield, %
(ee, %)
8aꢀf
entry
compound
7a: R = iPr
yield, %
1
2
3
4
5
6
23a (0)
65b
ꢀ
7b: R = EtO2C
81 (77)
62 (85)
76 (63)
83 (>98)
45 (>98)
a Reaction conditions: 50 mol % L-isoleucine, DMSO, rt, 10 h.
7c: R = ClCH2
ꢀ
7d: R = 4-NO2-C6H4
7e: R = (MeO)2CH
7f: R = BnOCH2
ꢀ
ꢀ
21b
(5) Markert, M.; Scheffler, U.; Mahrwald, R. J. Am. Chem. Soc. 2009,
131, 16642.
a Yield related to isobutyraldehyde. b Yield related to isoleucine.
(6) Same results were obtained when used with 25 mol% isoleucine. In
these reactiones longer reaction times are required (up to 6ꢀ8 days at rt).
(7) With the exceptions of cross-aldol additions of isobutyraldehyde
1 as the ene component and 4-nitrobenzaldehyde 4 as the carbonyl
component: (a) Mase, N.; Tanaka, F.; Barbas, C. F., III. Angew. Chem.,
Int. Ed. 2004, 43, 2420. (b) Wang, W.; Li, H.; Wang, J. Tetrahedron Lett.
2005, 46, 5077. (c) Mase, N.; Nakai, Y.; Ohara, N.; Yoda, H.; Takabe,
K.; Tanaka, F.; Barbas, C. F., III. J. Am. Chem. Soc. 2006, 128, 734.
(8) Thus, for the first time by cleavage of acetal 8a an access to
optically pure aldehyde 7a is given. See Supporting Information.
(3) For an overview of organocatalyzed cross-aldol additions of
enolizable aldehydes, see: Scheffler, U.; Mahrwald, R. Synlett 2011, 1660.
(4) (a) Chiral sulfonamides: Kano, T.; Sugimoto, H.; Maruoka, K.
J. Am. Chem. Soc. 2011, 133, 18130. (b) Diarylprolinols: Hayashi, Y.;
Itoh, T.; Aratake, S.; Ishikawa, H. Angew. Chem., Int. Ed. 2008, 47, 2082.
(c) Diarylprolinos: Hayashi, Y.; Yasui, Y.; Kawamura, T.; Kojima, M.;
Ishikawa, H. Angew. Chem., Int. Ed. 2011, 50, 2804.
Org. Lett., Vol. 14, No. 8, 2012
2181